Collegium Pharmaceutical, Inc. Depreciation
Collegium Pharmaceutical, Inc. (COLL) reported Depreciation of $1.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. depreciation for the quarter ending 2026-06-30 was $1.81M, a 59.65% increase year-over-year.
- Collegium Pharmaceutical, Inc. depreciation for the quarter ending 2026-03-31 was $463.00K, a 57.56% decline year-over-year.
- Collegium Pharmaceutical, Inc. depreciation for the quarter ending 2025-12-31 was $923.00K, a 11.34% decline year-over-year.
- Collegium Pharmaceutical, Inc. depreciation for the quarter ending 2025-09-30 was $1.03M, a 9.20% increase year-over-year.
- Collegium Pharmaceutical, Inc. depreciation for fiscal 2025 was $4.18M, a 8.45% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. depreciation for fiscal 2024 was $3.86M, a 10.30% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. depreciation for fiscal 2023 was $3.50M, a 30.25% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. depreciation for fiscal 2022 was $2.68M, a 54.61% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.81M 10-Q · filed 2026-08-06 | $2.27M 10-Q · filed 2026-08-06 | $3.20M derived: sum of 3 quarters · filed 2026-08-06 | $4.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $463.00K 10-Q · filed 2026-05-07 | $1.39M derived: sum of 2 quarters · filed 2026-05-07 | $2.42M derived: sum of 3 quarters · filed 2026-05-07 | $3.55M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.96M derived: sum of 2 quarters · filed 2026-02-26 | $3.09M derived: sum of 3 quarters · filed 2026-08-06 | $4.18M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.03M 10-Q · filed 2025-11-06 | $2.17M derived: sum of 2 quarters · filed 2026-08-06 | $3.26M 10-Q · filed 2025-11-06 | $4.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.14M 10-Q · filed 2026-08-06 | $2.23M 10-Q · filed 2026-08-06 | $3.27M derived: sum of 3 quarters · filed 2026-08-06 | $4.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.09M 10-Q · filed 2026-05-07 | $2.13M derived: sum of 2 quarters · filed 2026-05-07 | $3.08M derived: sum of 3 quarters · filed 2026-05-07 | $4.03M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.99M derived: sum of 2 quarters · filed 2026-02-26 | $2.94M derived: sum of 3 quarters · filed 2026-02-26 | $3.86M 10-K · filed 2026-02-26 |
| 2024-09-30 | $946.00K 10-Q · filed 2025-11-06 | $1.90M derived: sum of 2 quarters · filed 2025-11-06 | $2.81M 10-Q · filed 2025-11-06 | $3.76M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $952.00K 10-Q · filed 2025-08-07 | $1.87M 10-Q · filed 2025-08-07 | $2.82M derived: sum of 3 quarters · filed 2026-02-26 | $3.65M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $917.00K 10-Q · filed 2025-05-08 | $1.87M derived: sum of 2 quarters · filed 2026-02-26 | $2.70M derived: sum of 3 quarters · filed 2026-02-26 | $3.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $949.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.78M derived: sum of 2 quarters · filed 2026-02-26 | $2.68M derived: sum of 3 quarters · filed 2026-02-26 | $3.50M 10-K · filed 2026-02-26 |
| 2023-09-30 | $835.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.73M derived: sum of 2 quarters · filed 2024-11-07 | $2.55M 10-Q · filed 2024-11-07 | $3.37M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.71M 10-Q · filed 2024-08-08 | $2.54M derived: sum of 3 quarters · filed 2025-02-27 | $3.02M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $817.00K 10-Q · filed 2024-05-09 | $1.64M derived: sum of 2 quarters · filed 2025-02-27 | $2.13M derived: sum of 3 quarters · filed 2025-02-27 | $2.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.31M derived: sum of 2 quarters · filed 2025-02-27 | $1.97M derived: sum of 3 quarters · filed 2025-02-27 | $2.68M 10-K · filed 2025-02-27 |
| 2022-09-30 | $488.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.14M derived: sum of 2 quarters · filed 2023-11-07 | $1.86M 10-Q · filed 2023-11-07 | $2.28M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.37M 10-Q · filed 2023-08-03 | $1.79M derived: sum of 3 quarters · filed 2024-02-22 | $2.24M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $715.00K 10-Q · filed 2023-05-04 | $1.14M derived: sum of 2 quarters · filed 2024-02-22 | $1.59M derived: sum of 3 quarters · filed 2024-02-22 | $2.01M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $872.00K derived: sum of 2 quarters · filed 2024-02-22 | $1.30M derived: sum of 3 quarters · filed 2024-02-22 | $1.74M 10-K · filed 2024-02-22 |
| 2021-09-30 | $448.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $873.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.31M 10-Q · filed 2022-11-03 | $1.59M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $425.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $864.00K 10-Q · filed 2022-08-04 | $1.15M derived: sum of 3 quarters · filed 2023-02-23 | $1.34M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $439.00K 10-Q · filed 2022-05-10 | $720.00K derived: sum of 2 quarters · filed 2023-02-23 | $915.00K derived: sum of 3 quarters · filed 2023-02-23 | $1.11M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $476.00K derived: sum of 2 quarters · filed 2023-02-23 | $672.00K derived: sum of 3 quarters · filed 2023-02-23 | $870.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $195.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $391.00K derived: sum of 2 quarters · filed 2021-11-04 | $589.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $394.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $198.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $731.00K 10-K · filed 2022-02-24 | |||
| 2018-12-31 | $1.07M 10-K · filed 2021-02-25 | |||
| 2018-03-31 | $482.00K 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | $336.00K 10-K · filed 2020-02-27 | |||
| 2017-03-31 | $208.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $258.00K 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $79.00K derived: sum of 2 quarters · filed 2018-03-07 | $125.00K derived: sum of 3 quarters · filed 2018-03-07 | $171.00K 10-K · filed 2018-03-07 |
| 2015-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $84.00K derived: sum of 2 quarters · filed 2015-11-12 | $130.00K 10-Q · filed 2015-11-12 | $176.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $46.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $92.00K 10-Q · filed 2015-08-12 | $138.00K derived: sum of 3 quarters · filed 2017-03-10 | $184.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $46.00K 10-Q/A · filed 2015-07-17 | $92.00K derived: sum of 2 quarters · filed 2017-03-10 | $138.00K derived: sum of 3 quarters · filed 2017-03-10 | $185.00K derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $92.00K derived: sum of 2 quarters · filed 2017-03-10 | $139.00K derived: sum of 3 quarters · filed 2017-03-10 | $187.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $93.00K derived: sum of 2 quarters · filed 2015-11-12 | $141.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $47.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $95.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $48.00K 10-Q/A · filed 2015-07-17 | |||
| 2013-12-31 | $169.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |